Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LYVISPAH safely and effectively. See full prescribing information for LYVISPAH. LYVISPAH (baclofen) oral granules Initial U.S. Approval: 1977
Medication labelWhy this: Advisory · dailymed-prescription
LYVISPAH is indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. LYVISPAH may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Limitations of Use LYVISPAH is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.
- generic_name
- baclofen
- product_names
- baclofen
- ndc
- 70257-412, 70257-412-87, 70257-414, 70257-414-87, 70257-416, 70257-416-87
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en